The 2nd European Conference of National Strategies for Chlamydia Trachomatis

Last May 23-24, 2013 the 2nd European Conference of National Strategies for Chlamydia trachomatis and Human Papillomavirus was held in Berlin. This is to discuss and provide an outstanding experience for learning and scientific exchange, a tradition consistent with previous European Chlamydia  and Papillomavirus conference. 

The organiser is confident that the conferece will spark the minds of both young as well as established researchers, epidemiologists, clinicians, health care funders, and laboratory doctors, and start valuable discussions, and enrich the Proceedings of this Symposium!

The challenge of the European health care is the recognition of Chlamydia trachomatis and Human Papillomovirus as a public health problem. Nucleic acid amplification tests are the optimal ones for the diagnosis of Chlamydia trachomatis, but are not routinely used in many countries. On-demand Human Papillomovirus vaccination provision tends to miss the lower socioeconomic groups and minorities, which are exactly the groups that are missed by the opportunistic cervical screening that still prevails in Europe.

This will be a great start to have a proper handling of this spreading infections.

For more details about the EFFECTIVE MEDICINES check TREATMENT OF CHLAMYDIA.